Low Profile for SDI Work on Campus

WASHINGTON--For J.R. Shealy, an electrical engineer at Cornell University, the Strategic Defense Initiative (SDI) isn’t about shooting down missiles. Instead, it’s a way to fund his pioneering research on growing semiconductor crystals. WASHINGTON--James A. Ionson’s four-year tenure as director of SDI’s Innovative Science and Technology (IST) program was punctuated by controversy over the idea of a strategic defense and the role of the academic community in SDI resea

Written byDaniel Charles
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON--James A. Ionson’s four-year tenure as director of SDI’s Innovative Science and Technology (IST) program was punctuated by controversy over the idea of a strategic defense and the role of the academic community in SDI research. Although he left last month to start a new high-tech. research firm, Ionson’s brashness and enthusiasm for new technology remain undiminished. His disdain for academic critics of SDI also shows no signs of mellowing.

Ionson glowered when asked, during an interview shortly before his April 8 departure, whether the IST program was founded partly as a way to generate more support for SDI on university campuses. “That’s garbage, absolute garbage,” he growled. “And when I’m out [in private business] I’ll make that even stronger, because I can get away with more. 1 have more respect for the academic community than my opponents seem to have,” Ionson said about the origins of his program. “You ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies